Kerala Ayurveda Ltd (530163) Stock Price & News

530163:BOM

Kerala Ayurveda Ltd

₹148.50

+1.89%

(+2.75) 1D

Oct 15, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 530163...

Open

₹149.95

High

₹153.90

Low

₹143.25

Mkt. cap

1.93B

Avg. vol.

13.88K

Volume

10.50K

52-wk high

₹448.00

52-wk low

₹141.00

EPS

-₹23.58

Shares outstanding

10.56M

No. of employees

414

Open

₹149.95

High

₹153.90

Low

₹143.25

Mkt. cap

1.93B

Avg. vol.

13.88K

Volume

10.50K

52-wk high

₹448.00

52-wk low

₹141.00

EPS

-₹23.58

Shares outstanding

10.56M

No. of employees

414

Related stocks

530313

Kimia Biosciences Ltd

₹33.56

+2.57%

538964

Mercury Laboratories Ltd

₹760.00

0.00%

PAR

Par Drugs and Chemicals Ltd

₹111.00

-2.96%

531726

Panchsheel Organics Ltd

₹101.05

-2.88%

News stories

From web sources and news partners

TradingView

31 minutes ago

S&P 500's march to 8,000 hinges on 'very, very strong' third quarter

The Motley Fool

4 minutes ago

History Says Berkshire Hathaway Stock Holds Up When the Market Falls: It Beat the S&P 500 in 11 of 13 Down Years

BNN Bloomberg

58 minutes ago

The bull market turns four. Is age really just a number?: Stan Wong

Yahoo Finance

1 hour ago

US Stock Futures Fall as AI Valuation Concerns Offset Anthropic Revenue Growth and TSMC Record Profit: Dow Jones, S&P, Nasdaq, Wall Street

About Kerala Ayurveda Ltd

CEO-

Employees414

Founded1945

Headquarters-

SectorPharmaceutical industry

Websitekeralaayurveda.biz

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	348.38M	329.59M	347.37M	331.93M
Cost of goods sold	101.17M	42.72M	97.33M	41.81M
Cost of revenue	101.17M	42.72M	97.33M	41.81M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	158.40M	156.34M	365.06M	188.39M
Operating expense	306.65M	313.52M	335.10M	347.14M
Total operating expenses	407.82M	356.23M	432.43M	388.95M
Operating income	-59.44M	-26.64M	-85.06M	-57.02M
Other non operating income	17.02M	11.32M	-123.82M	2.61M
EBT including unusual items	-68.22M	-43.71M	-79.82M	-82.31M
EBT excluding unusual items	-68.22M	-43.71M	-160.30M	-82.31M
Income tax expense	-4.63M	2.27M	-5.86M	-1.54M
Effective tax rate	6.79%	-5.19%	7.35%	1.87%
Other operating expenses	138.34M	145.67M	-59.20M	140.03M
Net income	-63.38M	-44.45M	-75.30M	-79.78M
Net profit margin	-18.19%	-13.49%	-21.68%	-24.03%
Earnings per share	-	-	-	-
Interest and investment income	-	-	86.00K	-
Interest expense	-25.81M	-28.38M	-10.21M	-27.90M
Net interest expenses	-25.81M	-28.38M	-10.12M	-27.90M
Depreciation and amortization charges	9.90M	11.50M	16.91M	18.73M
EBITDA	-46.21M	-21.38M	-76.88M	-43.30M
Gain or loss from assets sale	-	-	-	-

Ask anything